Goldman Sachs Knock-Out LLY/ DE000GG312P4 /
25/06/2024 14:49:35 | Chg.+0.39 | Bid17:41:44 | Ask17:41:44 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
18.54EUR | +2.15% | 19.37 Bid Size: 10,000 |
19.40 Ask Size: 10,000 |
Eli Lilly and Co | 697.9299 USD | 31/12/2078 | Call |
GlobeNewswire
21/06
HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
GlobeNewswire
11/06
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire
10/06
Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...
GlobeNewswire
06/06
Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
GlobeNewswire
30/05
Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire
30/05
Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire
24/05
Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
GlobeNewswire
16/05
BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire
16/05
Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire
13/05
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
13/05
Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire
08/05
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update